Centessa Pharmaceuticals plc (CNTA) Financials

CNTA Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 377.4 million 118.0 million
2023-06-30 392.9 million 116.3 million
2023-03-31 403.9 million 110.6 million
2022-12-31 444.3 million 108.1 million

CNTA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -37.4 million 7.6 million
2023-06-30 -44.1 million 7.2 million
2023-03-31 -47.9 million 7.2 million
2022-12-31 -52.2 million 6.6 million

CNTA Net Income

No data available :(

CNTA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 281.3 million - 9.5 million
2023-06-30 303.6 million - 9.6 million
2023-03-31 346.2 million - 9.7 million
2022-12-31 393.6 million - -

CNTA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 96.6 million
2023-06-30 95.2 million
2023-03-31 94.9 million
2022-12-31 94.6 million

CNTA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 43000 28.2 million 12.0 million -
2023-06-30 10000 33.7 million 13.3 million -
2023-03-31 88000 32.8 million 16.1 million -
2022-12-31 652000 27.8 million 13.8 million -

CNTA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 236618
2023-06-30 - 237762
2023-03-31 - 89807
2022-12-31 - 36269

CNTA

Price: $9.67

52 week price:
3.96
12.45

Earnings Per Share: -1.57 USD

P/E Ratio: -6.56

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 66900

Market Capitalization: 1.1 billion

Links: